cagrilintide tirzepatide combination trial Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 Cagrilintide vs retatrutide: amylin analogue

Some in the industry say more enforcement is needed

Photos & Fonts You Can Use

This might involve pharmacist-led medication management, tailored marketing for store products that support GLP-1 use (e.g., high-protein, low-calorie, fiber-rich), and access to nutrition guidance and resources.

Adults with type 2 diabetes assigned an SGLT2 inhibitor or a GLP-1 receptor agonist during cardiovascular outcomes trials derived benefit from the therapies regardless of whether they were prescribed insulin, according to a meta-analysis.In an analysis of data across eight large, multiyear CV outcomes trials for three classes of diabetes agents, researchers also found that participants using

GLP-1 therapies are changing the landscape of obesity and Type 2 diabetes treatment, and researchers at UT San Antonio are helping shape what comes next

Nausea affects many semaglutide users, particularly during dose escalation